André Baruchel

20.6k total citations · 3 hit papers
333 papers, 9.7k citations indexed

About

André Baruchel is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, André Baruchel has authored 333 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Hematology, 171 papers in Public Health, Environmental and Occupational Health and 90 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in André Baruchel's work include Acute Lymphoblastic Leukemia research (165 papers), Acute Myeloid Leukemia Research (113 papers) and Childhood Cancer Survivors' Quality of Life (75 papers). André Baruchel is often cited by papers focused on Acute Lymphoblastic Leukemia research (165 papers), Acute Myeloid Leukemia Research (113 papers) and Childhood Cancer Survivors' Quality of Life (75 papers). André Baruchel collaborates with scholars based in France, Netherlands and Germany. André Baruchel's co-authors include Guy Leverger, Rob Pieters, Lewis B. Silverman, Martin Schrappe, Thierry Leblanc, Jacqueline Clavel, Brigitte Nelken, Stephen P. Hunger, Denis Hémon and Andrea Biondi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

André Baruchel

313 papers receiving 9.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

2015 592 citations Stephen P. Hunger, Rob Pieters et al. Journal of Clinical Oncology profile →
L‐asparaginase treatment in acute lymphoblastic leukemia

2010 445 citations Rob Pieters, Stephen P. Hunger et al. profile →
T cell malignancies after CAR T cell therapy in the DESCAR-T registry

2025 23 citations Nicolas Boissel, André Baruchel et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
André Baruchel	4.3k	4.3k	3.0k	2.4k	1.6k	333	9.7k
Selina M. Luger	5.4k 1.2×	3.2k 0.8×	2.9k 1.0×	1.2k 0.5×	2.9k 1.8×	304	9.7k
Jacob M. Rowe	7.9k 1.8×	5.6k 1.3×	3.0k 1.0×	1.6k 0.7×	3.0k 1.8×	317	12.9k
Wendy Stock	6.1k 1.4×	4.3k 1.0×	3.5k 1.2×	1.9k 0.8×	3.6k 2.2×	463	12.1k
William L. Carroll	5.1k 1.2×	8.7k 2.0×	2.8k 0.9×	5.6k 2.4×	2.8k 1.7×	316	13.6k
Jeffrey E. Rubnitz	8.0k 1.8×	8.3k 2.0×	4.1k 1.4×	4.1k 1.7×	2.8k 1.8×	278	14.9k
Gaston K. Rivera	4.6k 1.1×	6.9k 1.6×	2.2k 0.7×	3.9k 1.7×	2.1k 1.3×	166	11.2k
William G. Woods	3.6k 0.8×	2.4k 0.6×	1.8k 0.6×	1.3k 0.6×	1.5k 0.9×	209	7.8k
Meir Wetzler	5.0k 1.2×	1.9k 0.4×	3.0k 1.0×	569 0.2×	2.1k 1.3×	245	8.6k
Guy Leverger	2.7k 0.6×	1.9k 0.5×	1.2k 0.4×	1.1k 0.5×	1.1k 0.7×	242	6.0k
Bruce Bostrom	2.1k 0.5×	2.9k 0.7×	1.2k 0.4×	1.9k 0.8×	1.1k 0.7×	129	6.0k

Countries citing papers authored by André Baruchel

Since Specialization

Citations

This map shows the geographic impact of André Baruchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Baruchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Baruchel more than expected).

Fields of papers citing papers by André Baruchel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Baruchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Baruchel. The network helps show where André Baruchel may publish in the future.

Co-authorship network of co-authors of André Baruchel

This figure shows the co-authorship network connecting the top 25 collaborators of André Baruchel. A scholar is included among the top collaborators of André Baruchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Baruchel. André Baruchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simonin, Mathieu, Nicolas Boissel, Arnaud Petit, et al.. (2025). Prognostic impact of the PredicT-ALL classifier in the AALL0434 trial: a model combining NGS, MRD, and WBC at diagnosis. Blood Advances. 9(20). 5323–5326.

Lamble, Adam J., Sandra D. Bohling, Kara L. Davis, et al.. (2025). Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement. HemaSphere. 9(11). e70247–e70247.

Goldwirt, Lauriane, Mathieu Simonin, Marie-Émilie Dourthe, et al.. (2024). Monocentric experience of venetoclax‐based regimen in paediatric refractory and relapsed AML/MDS. British Journal of Haematology. 206(1). 209–214.

Auquier, Pascal, Virginie Gandemer, Yves Bertrand, et al.. (2024). Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population. Cancer Medicine. 13(3). e6821–e6821. 2 indexed citations

Auquier, Pascal, Yves Bertrand, Marie‐Dominique Tabone, et al.. (2023). Impact of childhood leukemia on siblings: their long-term perception of family functioning and its relationship with their psychosocial characteristics using structural equation modeling. Journal of Cancer Survivorship. 18(4). 1403–1415.

Berrou, Jeannig, Emmanuelle Clappier, Jean‐Michel Cayuela, et al.. (2022). Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL). Journal of Clinical Medicine. 11(22). 6761–6761. 4 indexed citations

Auquier, Pascal, Zeinab Hamidou, Yves Bertrand, et al.. (2022). Brothers and sisters of childhood acute leukemia survivors: Their long‐term quality of life and its determinants. Cancer Medicine. 12(5). 6200–6212. 4 indexed citations

Calvo, Julien, Sandrine Poglio, Thierry Leblanc, et al.. (2021). Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop. Blood Advances. 5(2). 513–526. 23 indexed citations

Taj, Mary, Anthony V. Moorman, Arnaud Petit, et al.. (2021). Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols. Leukemia. 36(1). 263–266. 4 indexed citations

10.

Fenneteau, Odile, et al.. (2021). Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity. Cancers. 13(4). 777–777. 14 indexed citations

11.

Vercasson, Camille, Pascal Auquier, Gérard Michel, et al.. (2020). Quality of life in parents of childhood leukemia survivors. A French Childhood Cancer Survivor Study for Leukemia study. Pediatric Blood & Cancer. 67(10). e28419–e28419. 12 indexed citations

12.

Alcantara, Marion, Mathieu Simonin, Ludovic Lhermitte, et al.. (2019). Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia. Blood Advances. 3(13). 1981–1988. 14 indexed citations

13.

Raymond, Gerald V., Patrick Aubourg, Asif Paker, et al.. (2018). Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(3). 538–548. 82 indexed citations

14.

Suttorp, Meinolf, Markus Metzler, Frédéric Millot, et al.. (2018). Generic formulations of imatinib for treatment of Philadelphia chromosome–positive leukemia in pediatric patients. Pediatric Blood & Cancer. 65(12). e27431–e27431. 10 indexed citations

15.

Petit, Arnaud, Amélie Trinquand, Sylvie Chevret, et al.. (2017). Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia. Blood. 131(3). 289–300. 61 indexed citations

16.

Cahu, Xavier, Julien Calvo, Sandrine Poglio, et al.. (2017). Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia. Blood Advances. 1(20). 1760–1772. 43 indexed citations

17.

Giovannini‐Chami, Lisa, Alice Hadchouel, André Baruchel, et al.. (2015). Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment. Pediatric Pulmonology. 51(2). 203–216. 25 indexed citations

18.

Zwaan, C. Michel, Carmelo Rizzari, Françoise Méchinaud, et al.. (2013). Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium. Journal of Clinical Oncology. 31(19). 2460–2468. 66 indexed citations

19.

Bally, Cécile, Jehane Fadlallah, Guy Leverger, et al.. (2012). Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group. Journal of Clinical Oncology. 30(14). 1641–1646. 32 indexed citations

20.

Hollink, Iris H.I.M., Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, et al.. (2009). Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. Blood. 113(23). 5951–5960. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact